跳到主要內容區

陳俊良助理教授論文著作

1. Chen HY*, Lin YH*, Wu JC, Hu S, Yang SH, Chen JL, Chen YC*, Lo SS. Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: A 1-year follow-up cohort study.   J Ethnopharmacol 2015:159: 189-196, (January) (CMRPG3B0761) (*: Equal Contributors) (SCI; IF= 2.981.; Integrative & Complementary Medicine 4/26)

2. Lee CP, Chen Y, Jiang KH, Chu CL, Hsu SC, Chen JL, Chen CY*. The prevalence and correlates of the positive androgen deficiency in the aging male  (ADAM) questionnaire among psychiatric outpatients: A cross-sectional survey of 176 men in a general hospital in Taiwan. Neuropsychiatr Dis Treat 2015: 11: 185-189, (January)  (SCI; IF = 2.198; Psychiatry 76/142)

3. Chen HY, Lin YH, Hu S, Yang SH, Chen JL, Chen YC*. Identifying Chinese herbal medicine network for eczema: Implications from a nationwide prescription database. Evid Based Complement Alternat Med 2015, Article ID 347164, doi:10.1155/ 2015/ 347164. Published online 2015 (January 22) (CMRPG3B0761) (SCI; IF= 1.740; Integrative & Complementary Medicine 10/26)

4. Kao TI, Yang SH, Chen JL, Lee SL*. Effects of Xiao-Qing-Long decoction    combined with Xiang-Sha-Liu-Jun-Zi decoction on airway hyperresponsiveness and cytokine levels in murine model of allergic asthma. J Chengdu University of TCM 2015: 38(1): 21-24, (March)

5. Yang SH*, Kao TI, Chiang BL, Chen HY, Chen KH, Chen JL. Immune-modulatory effects of Bu-Zhone-Yi-Qi-Tang in ovalbumin-induced murine model of allergic asthma.  PloS One 2015: 10(6): e0127636, 2015, doi:10.1371/journal.pone.0127636, published online 2015 (June). (SCI; IF = 2.806; Multidisciplinary Sciences 15/64)

6. Lee CP, Chu CL, Chen Y, Jiang KH, Chen JL, Chen CY*. The Chinese version of the gotland male depression scale (GMDS): mokken scaling. J Affect Disord 2015: 186: 48-52, (November) (SCI; IF = 3.432; Psychiatry 26/139)

7. Chiao SL, Lin YH, Chen JL, Yang SH*. Perspective on Taiwan international health care: integrate aromatherapy into traditional Chinese medicine.  J Chin Med 2015: 26(2): 2602007-2602019, (December) (CCMP98-RD-042)

8. Lee CP, Chen Y, Jiang KH, Chu CL, Chiu YW, Chen JL, Chen CY*.  Development of a short version of the aging males’ symptoms scale: Mokken scaling analysis and rasch analysis. Aging Male 2016:19(2): 117-123, (June)  (SCI; IF = 2.108; Urology & Nephrology 38/77)

9. Lai WY, Lin PY, Yu CH, Tseng HM, Yang SH, Ou LS, Yao TC, Chen JL*.  Impact of an integrative healthcare quality improvement program for asthmatic children and primary care-givers: A hospital-based observational preliminary  report. J Chin Med 2016: 27(1): 2701001, (June) (PMRPG5C0021) (Corresponding author) Doi:10.3966/241139642016062701001

10.Hsu PY, Yang SH, Tsang NM, Fan KH, Hsieh CH, Lin JR, Hong JH, Lin YC,   Chen HY, Yang CT, Yang CW, Chen JL*.  Efficacy of traditional Chinese medicine in xerostomia and quality of life during radiotherapy for head and neck cancer: a prospective pilot study.  Evid Based Complement Alternat Med:  2016, Article ID: 8359251. doi: 10.1155/ 2016/ 8359251. Published online 2016 (August) (CMRPG3C0301) (Corresponding author) (SCI; IF= 1.740; Integrative & Complementary Medicine 10/26)

11. Lee CP, Chiu YW, Chu CL, Chen Y, Jiang KH, Chen JL, Chen CY*.  A  reliability generalization meta-analysis of coefficient alpha and test-retest coefficient for the aging males’ symptoms (AMS) scale.  Aging Male 2016: 19(4): 244-253, (December) doi: 10.1080/13685538.2016.1246525. (Epub ahead of print, November 22) (SCI; IF = 2.108; Urology & Nephrology 38/77)

12. Tsai PJ, Lin YH, Chen JL, Yang SH, Chen YC, Chen HY*.  Identifying Chinese herbal medicine network for endometriosis: Implications from a population-based database in Taiwan. Evid Based Complement Alternat Med 2017; 2017:7501015. doi: 10.1155/ 2017/7501015. Epub: 2017 (June 27) (MOST105-2634-E-010-001) (SCI; IF= 1.740; Integrative & Complementary Medicine 10/26)

13. Yang CW, Chen HY, Chen JL, Yang SH. Therapeutic efficacy of traditional Chinese medicine on quality of life and heart rate variability among patients in long-term care system in Taiwan. J Chin Med 29(1): 42-59, 2018 (June)  (MOHW105-CMAP-M-114-000107)

14.Chen W, Chen HY, Yang YH, Yang SH, Yang CW, Wu YH, Chen JL*. An investigation of the prescription patterns of Chinese herbal products for chronic glomerulonephritis patients: A hospital-based cross-sectional study. Evid  Based Complement Alternat Med 2018, Article ID 5080764, Nov. 15, 2018.   (CORPG1G0061) (CLRPG6G0041) (Corresponding author)

15. Wang TJ, Lien ASY, Chen JL, Lin CH, Yang YS, Yang SH.  A randomized clinical efficacy trial of red yeast rice (Monascus Pilosus) against hyperlipidemia.  Am J Chin Med 2019: 47(2), 1-13, (March)   (SCRPD1A0011) (CLRPG3D0043).

16. Chen HY, Pan HC, Chen YC, Chen YC, Lin YH, Yang SH, Chen JL, Wu HT.  Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: A population-based cohort study. BMC Complement Altern Med 19(1): 81.doi: 10.1186/s12906-019-2491-y, April 3, 2019. (CMRPG5D0111) (104-2320- B182A-013).

17. Lee TH*, Chen JL*, Liu PS*, Tsai MM, Wang SJ, Hsieh HL.  Rottlerin, a   natural polyphenol compound, inhibits upregulation of matrix    metalloproteinase-9 and brain astrocytic migration by reducing PKC-δ-dependent ROS signal. J Neuroinflammation 17:177, 2020 (June) (*: Equal Contributors) (MOST107-2320-B-255-003),  (MOST108-2320-B- 255-002-MY3), (CMRPF1F0132), (CMRPF1H0051),   (CMRPF1I0041), (CMRPF1H0052),    (CMRPF1I0042), (ZRRPF3H0131),   (ZRRPF3J0081).

18. Lu YC, Yang CW, Lin YH, Hsueh JY, Chen JL, Yang SH, Chen YC, Chen   HY.  Identifying the Chinese herbal medicine network and core formula for allergic rhinitis on a real-world database. Evid Based Complement Alternat Med2020: 5979708, 2020 (November) (108-2320-B-182A-009-MY3).

19. Lee TH*, Liu PS*, Tsai MM*, Chen JL, Wang SJ, Hsieh HL. The COX-2-  derived PGE2 autocrine contributes to bradykinin-induced matrix metalloproteinase-9 expression and astrocytic migration via STAT3 signaling.   Cell Commun Signal 18: 185, 2020 (November) (*: Equal Contributors) (MOST107-2320-B-255-003) (MOST108-2320-B-255-002-MY3)     (CMRPF1F0132, CMRPF1H0051~3, CMRPF1I0041~2) (ZRRPF3H0131,  ZRRPF3J0081, ZRRPF3K0111)

20.Guo JCL, Pan HC, Yeh BY, Lu YC, Chen JL, Yang CW, Chen YC, Lin YH, Chen HY. Associations between using Chinese herbal medicine and long-term  outcome among pre-dialysis diabetic nephropathy patients: A retrospective  population-based cohort study.  Front Pharmacol. 2021; 12: 616522    February 2021, (CMRPG5D0111) (CMRPG1J0021) (CMRPG1J0022)  (SCRPD1K0401) (104-2320-B-182A-013) (108-2320-B-182A-009-MY3)

21.Peng CH, Chen JL, Liao MF, Hsu JL, Hsu HC, Ro LS. Reappraisal of the prognostic factors of outcome and recovery time in patients with idiopathic Bell’s palsy: A retrospective single-center analysis. J Pers Med 11(3): 171, 2021  (March)

22.Hou HI*, Chen HY*, Lu JJ, Chang SC, Li HY, Jiang KH, Chen JL*. The relationships between leptin, genotype, and Chinese medicine body constitution  for obesity. Evid Based Complement Alternat Med 2021; 2021:5510552.  (CMRPG1H0051) (CMRPG1H0052) (CMRPG1F0011) (CORPG1H0041) (CORPG1H0051 ) (*: Equal Contributors) (Corresponding author) (May)

23.Ku TC, Wang PH, Huang JL, Chen HY, Fang JT, Hsieh HL, Chen JL*. The survival outcome of nasopharyngeal cancer patients with traditional Chinese medicine external use: A hospital-based study. (CMRPG1F0011) (CORPG3H0371) (CORPG1J0021) (CMRPF1F0132) (CMRPF1H0051~3) (CMRPF1I0041~2) (MOST107-2320-B-255-003)  (MOST108-2320-B-255-002-MY3). (Corresponding author) (June)

瀏覽數: